These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2885701)
21. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Redding TW; Schally AV Proc Natl Acad Sci U S A; 1984 Jan; 81(1):248-52. PubMed ID: 6141560 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone. Torres-Aleman I; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of somatostatin analogs on prolactin secretion in rats pretreated with estrogen or haloperidol. Karashima T; Schally AV Proc Soc Exp Biol Med; 1987 May; 185(1):69-75. PubMed ID: 2883661 [TBL] [Abstract][Full Text] [Related]
26. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells. Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine. Brady SF; Cochran DW; Nutt RF; Holly FW; Bennett CD; Paleveda WJ; Curley PE; Arison BH; Saperstein R; Veber DF Int J Pept Protein Res; 1984 Feb; 23(2):212-22. PubMed ID: 6142022 [TBL] [Abstract][Full Text] [Related]
28. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach. Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337 [TBL] [Abstract][Full Text] [Related]
29. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice. Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223 [TBL] [Abstract][Full Text] [Related]
30. Somatostatin: analogs with selected biological activities. Brown M; Rivier J; Vale W Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications. Janecka A; Zubrzycka M Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935 [TBL] [Abstract][Full Text] [Related]
32. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Szende B; Zalatnai A; Schally AV Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204 [TBL] [Abstract][Full Text] [Related]
33. Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat. Murphy WA; Heiman ML; Lance VA; Mezo I; Coy DH Biochem Biophys Res Commun; 1985 Nov; 132(3):922-8. PubMed ID: 2866766 [TBL] [Abstract][Full Text] [Related]
34. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules. Zalatnai A; Schally AV Cancer Res; 1989 Apr; 49(7):1810-5. PubMed ID: 2564312 [TBL] [Abstract][Full Text] [Related]
35. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. Paz-Bouza JI; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1112-6. PubMed ID: 2881296 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones. Redding TW; Schally AV Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1078-82. PubMed ID: 6133278 [TBL] [Abstract][Full Text] [Related]
38. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin. Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612 [TBL] [Abstract][Full Text] [Related]
39. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons. Chieng B; Connor M; Christie MJ Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906 [TBL] [Abstract][Full Text] [Related]